Albendazole Therapy for Giant Subarachnoid Cysticerci
- 1 May 1992
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 49 (5) , 535-538
- https://doi.org/10.1001/archneur.1992.00530290123021
Abstract
Albendazole is considered to be the drug of choice for treatment of parenchymal brain cysticercosis. Its efficacy, however, for treatment of subarachnoid cysticerci has not been established, to our knowledge. In this study, we treated four patients who had giant subarachnoid cysticerci with albendazole at daily doses of 15 mg/kg of body weight for 8 days. Computed tomographic studies showed that all cysts disappeared 3 months after the end of treatment. This was associated with marked clinical improvement in every case. Our results indicated that albendazole is highly effective for treatment of this form of the disease.Keywords
This publication has 19 references indexed in Scilit:
- Plasma and CSF Levels of Albendazole and Praziquantel in Patients with NeurocysticercosisClinical Neuropharmacology, 1990
- Albendazole therapy for subarachnoid and ventricular cysticercosisJournal of Neurosurgery, 1990
- Lacunar Syndrome due to NeurocysticercosisArchives of Neurology, 1989
- Neurocysticercosis: An UpdateClinical Infectious Diseases, 1988
- Short Course of Albendazole Therapy for NeurocysticercosisArchives of Neurology, 1988
- Surgical considerations in neurocysticercosisChild's Nervous System, 1987
- Results of surgical treatment of neurocysticercosis in 69 casesJournal of Neurosurgery, 1986
- ELISA in the Diagnosis of NeurocysticercosisArchives of Neurology, 1986
- Praziquantel in the treatment of neurocysticercosisNeurology, 1985
- Therapy of Parenchymal Brain Cysticercosis with PraziquantelNew England Journal of Medicine, 1984